Partner Content Partner Content Learn about technological innovations at SMi’s Pre-Filled Sy... Learn about technological innovations at PFS
Events Partner Content 3rd Annual Dermatology Drug Development Summit Industry meeting on advancing derm drug development
Partner Content Partner Content Registration is Live for the Inaugural Respiratory Drug Deli... Registration is Live for the Inaugural Respiratory Drug
Views & Analysis Rare Disease Day: How the patient voice can tear down barrie... To have any impact, patient engagement needs to start with the drug development pathway, not at the point of licensing. That’s especially true in the rare disease space, where the unme
Events Partner Content SMi’s 19th Annual Pain Therapeutics Conference SMi's 19th Annual Pain Therapeutics Conference
Views & Analysis Cost concerns with the new NHS pricing scheme A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
